This contract expires in 317 days (Feb 28, 2027).
FIRM FIXED PRICENO SET ASIDE USED.
RLS (USA) INC. - RADIOPHARMACEUTICALS NUCLEAR MEDICINE
PIID: 36C25226P0239Solicitation ID: 36C25226Q0243
Signed Date: Feb 26, 2026Effective Date: Mar 1, 2026End Date: Closes in 317 days
Key Details
Description
RADIOPHARMACEUTICALS NUCLEAR MEDICINE
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors